Tag Archives: de

#435583 Soft Self-Healing Materials for Robots ...

If there’s one thing we know about robots, it’s that they break. They break, like, literally all the time. The software breaks. The hardware breaks. The bits that you think could never, ever, ever possibly break end up breaking just when you need them not to break the most, and then you have to try to explain what happened to your advisor who’s been standing there watching your robot fail and then stay up all night fixing the thing that seriously was not supposed to break.

While most of this is just a fundamental characteristic of robots that can’t be helped, the European Commission is funding a project called SHERO (Self HEaling soft RObotics) to try and solve at least some of those physical robot breaking problems through the use of structural materials that can autonomously heal themselves over and over again.

SHERO is a three year, €3 million collaboration between Vrije Universiteit Brussel, University of Cambridge, École Supérieure de Physique et de Chimie Industrielles de la ville de Paris (ESPCI-Paris), and Swiss Federal Laboratories for Materials Science and Technology (Empa). As the name SHERO suggests, the goal of the project is to develop soft materials that can completely recover from the kinds of damage that robots are likely to suffer in day to day operations, as well as the occasional more extreme accident.

Most materials, especially soft materials, are fixable somehow, whether it’s with super glue or duct tape. But fixing things involves a human first identifying when they’re broken, and then performing a potentially skill, labor, time, and money intensive task. SHERO’s soft materials will, eventually, make this entire process autonomous, allowing robots to self-identify damage and initiate healing on their own.

Photos: SHERO Project

The damaged robot finger [top] can operate normally after healing itself.

How the self-healing material works
What these self-healing materials can do is really pretty amazing. The researchers are actually developing two different types—the first one heals itself when there’s an application of heat, either internally or externally, which gives some control over when and how the healing process starts. For example, if the robot is handling stuff that’s dirty, you’d want to get it cleaned up before healing it so that dirt doesn’t become embedded in the material. This could mean that the robot either takes itself to a heating station, or it could activate some kind of embedded heating mechanism to be more self-sufficient.

The second kind of self-healing material is autonomous, in that it will heal itself at room temperature without any additional input, and is probably more suitable for relatively minor scrapes and cracks. Here are some numbers about how well the healing works:

Autonomous self-healing polymers do not require heat. They can heal damage at room temperature. Developing soft robotic systems from autonomous self-healing polymers excludes the need of additional heating devices… The healing however takes some time. The healing efficiency after 3 days, 7 days and 14 days is respectively 62 percent, 91 percent and 97 percent.

This material was used to develop a healable soft pneumatic hand. Relevant large cuts can be healed entirely without the need of external heat stimulus. Depending on the size of the damage and even more on the location of damage, the healing takes only seconds or up to a week. Damage on locations on the actuator that are subjected to very small stresses during actuation was healed instantaneously. Larger damages, like cutting the actuator completely in half, took 7 days to heal. But even this severe damage could be healed completely without the need of any external stimulus.

Applications of self-healing robots
Both of these materials can be mixed together, and their mechanical properties can be customized so that the structure that they’re a part of can be tuned to move in different ways. The researchers also plan on introducing flexible conductive sensors into the material, which will help sense damage as well as providing position feedback for control systems. A lot of development will happen over the next few years, and for more details, we spoke with Bram Vanderborght at Vrije Universiteit in Brussels.

IEEE Spectrum: How easy or difficult or expensive is it to produce these materials? Will they add significant cost to robotic grippers?

Bram Vanderborght: They are definitely more expensive materials, but it’s also a matter of size of production. At the moment, we’ve made a few kilograms of the material (enough to make several demonstrators), and the price already dropped significantly from when we ordered 100 grams of the material in the first phase of the project. So probably the cost of the gripper will be higher [than a regular gripper], but you won’t need to replace the gripper as often as other grippers that need to be replaced due to wear, so it can be an advantage.

Moreover due to the method of 3D printing the material, the surface is smoother and airtight (so no post-processing is required to make it airtight). Also, the smooth surface is better to avoid contamination for food handling, for example.

In commercial or industrial applications, gradual fatigue seems to be a more common issue than more abrupt trauma like cuts. How well does the self-healing work to improve durability over long periods of time?

We did not test for gradual fatigue over very long times. But both macroscopic and microscopic damage can be healed. So hopefully it can provide an answer here as well.

Image: SHERO Project

After developing a self-healing robot gripper, the researchers plan to use similar materials to build parts that can be used as the skeleton of robots, allowing them to repair themselves on a regular basis.

How much does the self-healing capability restrict the material properties? What are the limits for softness or hardness or smoothness or other characteristics of the material?

Typically the mechanical properties of networked polymers are much better than thermoplastics. Our material is a networked polymer but in which the crosslinks are reversible. We can change quite a lot of parameters in the design of the materials. So we can develop very stiff (fracture strain at 1.24 percent) and very elastic materials (fracture strain at 450 percent). The big advantage that our material has is we can mix it to have intermediate properties. Moreover, at the interface of the materials with different mechanical properties, we have the same chemical bonds, so the interface is perfect. While other materials, they may need to glue it, which gives local stresses and a weak spot.

When the material heals itself, is it less structurally sound in that spot? Can it heal damage that happens to the same spot over and over again?

In theory we can heal it an infinite amount of times. When the wound is not perfectly aligned, of course in that spot it will become weaker. Also too high temperatures lead to irreversible bonds, and impurities lead to weak spots.

Besides grippers and skins, what other potential robotics applications would this technology be useful for?

Most of self healing materials available now are used for coatings. What we are developing are structural components, therefore the mechanical properties of the material need to be good for such applications. So maybe part of the skeleton of the robot can be developed with such materials to make it lighter, since can be designed for regular repair. And for exceptional loads, it breaks and can be repaired like our human body.

[ SHERO Project ] Continue reading

Posted in Human Robots

#435313 This Week’s Awesome Stories From ...

ARTIFICIAL INTELLIGENCE
Microsoft Invests $1 Billion in OpenAI to Pursue Holy Grail of Artificial Intelligence
James Vincent | The Verge
“i‘The creation of AGI will be the most important technological development in human history, with the potential to shape the trajectory of humanity,’ said [OpenAI cofounder] Sam Altman. ‘Our mission is to ensure that AGI technology benefits all of humanity, and we’re working with Microsoft to build the supercomputing foundation on which we’ll build AGI.’i”

ROBOTICS
UPS Wants to Go Full-Scale With Its Drone Deliveries
Eric Adams | Wired
“If UPS gets its way, it’ll be known for vehicles other than its famous brown vans. The delivery giant is working to become the first commercial entity authorized by the Federal Aviation Administration to use autonomous delivery drones without any of the current restrictions that have governed the aerial testing it has done to date.”

SYNTHETIC BIOLOGY
Scientists Can Finally Build Feedback Circuits in Cells
Megan Molteni | Wired
“Network a few LOCKR-bound molecules together, and you’ve got a circuit that can control a cell’s functions the same way a PID computer program automatically adjusts the pitch of a plane. With the right key, you can make cells glow or blow themselves apart. You can send things to the cell’s trash heap or zoom them to another cellular zip code.”

ENERGY
Carbon Nanotubes Could Increase Solar Efficiency to 80 Percent
David Grossman | Popular Mechanics
“Obviously, that sort of efficiency rating is unheard of in the world of solar panels. But even though a proof of concept is a long way from being used in the real world, any further developments in the nanotubes could bolster solar panels in ways we haven’t seen yet.”

FUTURE
What Technology Is Most Likely to Become Obsolete During Your Lifetime?
Daniel Kolitz | Gizmodo
“Old technology seldom just goes away. Whiteboards and LED screens join chalk blackboards, but don’t eliminate them. Landline phones get scarce, but not phones. …And the technologies that seem to be the most outclassed may come back as a the cult objects of aficionados—the vinyl record, for example. All this is to say that no one can tell us what will be obsolete in fifty years, but probably a lot less will be obsolete than we think.”

NEUROSCIENCE
The Human Brain Project Hasn’t Lived Up to Its Promise
Ed Yong | The Atlantic
“The HBP, then, is in a very odd position, criticized for being simultaneously too grandiose and too narrow. None of the skeptics I spoke with was dismissing the idea of simulating parts of the brain, but all of them felt that such efforts should be driven by actual research questions. …Countless such projects could have been funded with the money channeled into the HBP, which explains much of the furor around the project.”

Image Credit: Aron Van de Pol / Unsplash Continue reading

Posted in Human Robots

#434797 This Week’s Awesome Stories From ...

GENE EDITING
Genome Engineers Made More Than 13,000 Genome Edits in a Single Cell
Antonio Regalado | MIT Technology Review
“The group, led by gene technologist George Church, wants to rewrite genomes at a far larger scale than has currently been possible, something it says could ultimately lead to the ‘radical redesign’ of species—even humans.”

ROBOTICS
Inside Google’s Rebooted Robotics Program
Cade Metz | The New York Times
“Google’s new lab is indicative of a broader effort to bring so-called machine learning to robotics. …Many believe that machine learning—not extravagant new devices—will be the key to developing robotics for manufacturing, warehouse automation, transportation and many other tasks.

VIDEOS
Boston Dynamics Builds the Warehouse Robot of Jeff Bezos’ Dreams
Luke Dormehl | Digital Trends
“…for anyone wondering what the future of warehouse operation is likely to look like, this offers a far more practical glimpse of the years to come than, say, a dancing dog robot. As Boston Dynamics moves toward commercializing its creations for the first time, this could turn out to be a lot closer than you might think.”

TECHNOLOGY
Europe Is Splitting the Internet Into Three
Casey Newton | The Verge
“The internet had previously been divided into two: the open web, which most of the world could access; and the authoritarian web of countries like China, which is parceled out stingily and heavily monitored. As of today, though, the web no longer feels truly worldwide. Instead we now have the American internet, the authoritarian internet, and the European internet. How does the EU Copyright Directive change our understanding of the web?”

VIRTUAL REALITY
No Man’s Sky’s Next Update Will Let You Explore Infinite Space in Virtual Reality
Taylor Hatmaker | TechCrunch
“Assuming the game runs well enough, No Man’s Sky Virtual Reality will be a far cry from gimmicky VR games that lack true depth, offering one of the most expansive—if not the most expansive—VR experiences to date.”

3D PRINTING
3D Metal Printing Tries to Break Into the Manufacturing Mainstream
Mark Anderson | IEEE Spectrum
“It’s been five or so years since 3D printing was at peak hype. Since then, the technology has edged its way into a new class of materials and started to break into more applications. Today, 3D printers are being seriously considered as a means to produce stainless steel 5G smartphones, high-strength alloy gas-turbine blades, and other complex metal parts.”

Image Credit: ale de sun / Shutterstock.com Continue reading

Posted in Human Robots

#434658 The Next Data-Driven Healthtech ...

Increasing your healthspan (i.e. making 100 years old the new 60) will depend to a large degree on artificial intelligence. And, as we saw in last week’s blog, healthcare AI systems are extremely data-hungry.

Fortunately, a slew of new sensors and data acquisition methods—including over 122 million wearables shipped in 2018—are bursting onto the scene to meet the massive demand for medical data.

From ubiquitous biosensors, to the mobile healthcare revolution, to the transformative power of the Health Nucleus, converging exponential technologies are fundamentally transforming our approach to healthcare.

In Part 4 of this blog series on Longevity & Vitality, I expand on how we’re acquiring the data to fuel today’s AI healthcare revolution.

In this blog, I’ll explore:

How the Health Nucleus is transforming “sick care” to healthcare
Sensors, wearables, and nanobots
The advent of mobile health

Let’s dive in.

Health Nucleus: Transforming ‘Sick Care’ to Healthcare
Much of today’s healthcare system is actually sick care. Most of us assume that we’re perfectly healthy, with nothing going on inside our bodies, until the day we travel to the hospital writhing in pain only to discover a serious or life-threatening condition.

Chances are that your ailment didn’t materialize that morning; rather, it’s been growing or developing for some time. You simply weren’t aware of it. At that point, once you’re diagnosed as “sick,” our medical system engages to take care of you.

What if, instead of this retrospective and reactive approach, you were constantly monitored, so that you could know the moment anything was out of whack?

Better yet, what if you more closely monitored those aspects of your body that your gene sequence predicted might cause you difficulty? Think: your heart, your kidneys, your breasts. Such a system becomes personalized, predictive, and possibly preventative.

This is the mission of the Health Nucleus platform built by Human Longevity, Inc. (HLI). While not continuous—that will come later, with the next generation of wearable and implantable sensors—the Health Nucleus was designed to ‘digitize’ you once per year to help you determine whether anything is going on inside your body that requires immediate attention.

The Health Nucleus visit provides you with the following tests during a half-day visit:

Whole genome sequencing (30x coverage)
Whole body (non-contrast) MRI
Brain magnetic resonance imaging/angiography (MRI/MRA)
CT (computed tomography) of the heart and lungs
Coronary artery calcium scoring
Electrocardiogram
Echocardiogram
Continuous cardiac monitoring
Clinical laboratory tests and metabolomics

In late 2018, HLI published the results of the first 1,190 clients through the Health Nucleus. The results were eye-opening—especially since these patients were all financially well-off, and already had access to the best doctors.

Following are the physiological and genomic findings in these clients who self-selected to undergo evaluation at HLI’s Health Nucleus.

Physiological Findings [TG]

Two percent had previously unknown tumors detected by MRI
2.5 percent had previously undetected aneurysms detected by MRI
Eight percent had cardiac arrhythmia found on cardiac rhythm monitoring, not previously known
Nine percent had moderate-severe coronary artery disease risk, not previously known
16 percent discovered previously unknown cardiac structure/function abnormalities
30 percent had elevated liver fat, not previously known

Genomic Findings [TG]

24 percent of clients uncovered a rare (unknown) genetic mutation found on WGS
63 percent of clients had a rare genetic mutation with a corresponding phenotypic finding

In summary, HLI’s published results found that 14.4 percent of clients had significant findings that are actionable, requiring immediate or near-term follow-up and intervention.

Long-term value findings were found in 40 percent of the clients we screened. Long-term clinical findings include discoveries that require medical attention or monitoring but are not immediately life-threatening.

The bottom line: most people truly don’t know their actual state of health. The ability to take a fully digital deep dive into your health status at least once per year will enable you to detect disease at stage zero or stage one, when it is most curable.

Sensors, Wearables, and Nanobots
Wearables, connected devices, and quantified self apps will allow us to continuously collect enormous amounts of useful health information.

Wearables like the Quanttus wristband and Vital Connect can transmit your electrocardiogram data, vital signs, posture, and stress levels anywhere on the planet.

In April 2017, we were proud to grant $2.5 million in prize money to the winning team in the Qualcomm Tricorder XPRIZE, Final Frontier Medical Devices.

Using a group of noninvasive sensors that collect data on vital signs, body chemistry, and biological functions, Final Frontier integrates this data in their powerful, AI-based DxtER diagnostic engine for rapid, high-precision assessments.

Their engine combines learnings from clinical emergency medicine and data analysis from actual patients.

Google is developing a full range of internal and external sensors (e.g. smart contact lenses) that can monitor the wearer’s vitals, ranging from blood sugar levels to blood chemistry.

In September 2018, Apple announced its Series 4 Apple Watch, including an FDA-approved mobile, on-the-fly ECG. Granted its first FDA approval, Apple appears to be moving deeper into the sensing healthcare market.

Further, Apple is reportedly now developing sensors that can non-invasively monitor blood sugar levels in real time for diabetic treatment. IoT-connected sensors are also entering the world of prescription drugs.

Last year, the FDA approved the first sensor-embedded pill, Abilify MyCite. This new class of digital pills can now communicate medication data to a user-controlled app, to which doctors may be granted access for remote monitoring.

Perhaps what is most impressive about the next generation of wearables and implantables is the density of sensors, processing, networking, and battery capability that we can now cheaply and compactly integrate.

Take the second-generation OURA ring, for example, which focuses on sleep measurement and management.

The OURA ring looks like a slightly thick wedding band, yet contains an impressive array of sensors and capabilities, including:

Two infrared LED
One infrared sensor
Three temperature sensors
One accelerometer
A six-axis gyro
A curved battery with a seven-day life
The memory, processing, and transmission capability required to connect with your smartphone

Disrupting Medical Imaging Hardware
In 2018, we saw lab breakthroughs that will drive the cost of an ultrasound sensor to below $100, in a packaging smaller than most bandages, powered by a smartphone. Dramatically disrupting ultrasound is just the beginning.

Nanobots and Nanonetworks
While wearables have long been able to track and transmit our steps, heart rate, and other health data, smart nanobots and ingestible sensors will soon be able to monitor countless new parameters and even help diagnose disease.

Some of the most exciting breakthroughs in smart nanotechnology from the past year include:

Researchers from the École Polytechnique Fédérale de Lausanne (EPFL) and the Swiss Federal Institute of Technology in Zurich (ETH Zurich) demonstrated artificial microrobots that can swim and navigate through different fluids, independent of additional sensors, electronics, or power transmission.

Researchers at the University of Chicago proposed specific arrangements of DNA-based molecular logic gates to capture the information contained in the temporal portion of our cells’ communication mechanisms. Accessing the otherwise-lost time-dependent information of these cellular signals is akin to knowing the tune of a song, rather than solely the lyrics.

MIT researchers built micron-scale robots able to sense, record, and store information about their environment. These tiny robots, about 100 micrometers in diameter (approximately the size of a human egg cell), can also carry out pre-programmed computational tasks.

Engineers at University of California, San Diego developed ultrasound-powered nanorobots that swim efficiently through your blood, removing harmful bacteria and the toxins they produce.

But it doesn’t stop there.

As nanosensor and nanonetworking capabilities develop, these tiny bots may soon communicate with each other, enabling the targeted delivery of drugs and autonomous corrective action.

Mobile Health
The OURA ring and the Series 4 Apple Watch are just the tip of the spear when it comes to our future of mobile health. This field, predicted to become a $102 billion market by 2022, puts an on-demand virtual doctor in your back pocket.

Step aside, WebMD.

In true exponential technology fashion, mobile device penetration has increased dramatically, while image recognition error rates and sensor costs have sharply declined.

As a result, AI-powered medical chatbots are flooding the market; diagnostic apps can identify anything from a rash to diabetic retinopathy; and with the advent of global connectivity, mHealth platforms enable real-time health data collection, transmission, and remote diagnosis by medical professionals.

Already available to residents across North London, Babylon Health offers immediate medical advice through AI-powered chatbots and video consultations with doctors via its app.

Babylon now aims to build up its AI for advanced diagnostics and even prescription. Others, like Woebot, take on mental health, using cognitive behavioral therapy in communications over Facebook messenger with patients suffering from depression.

In addition to phone apps and add-ons that test for fertility or autism, the now-FDA-approved Clarius L7 Linear Array Ultrasound Scanner can connect directly to iOS and Android devices and perform wireless ultrasounds at a moment’s notice.

Next, Healthy.io, an Israeli startup, uses your smartphone and computer vision to analyze traditional urine test strips—all you need to do is take a few photos.

With mHealth platforms like ClickMedix, which connects remotely-located patients to medical providers through real-time health data collection and transmission, what’s to stop us from delivering needed treatments through drone delivery or robotic telesurgery?

Welcome to the age of smartphone-as-a-medical-device.

Conclusion
With these DIY data collection and diagnostic tools, we save on transportation costs (time and money), and time bottlenecks.

No longer will you need to wait for your urine or blood results to go through the current information chain: samples will be sent to the lab, analyzed by a technician, results interpreted by your doctor, and only then relayed to you.

Just like the “sage-on-the-stage” issue with today’s education system, healthcare has a “doctor-on-the-dais” problem. Current medical procedures are too complicated and expensive for a layperson to perform and analyze on their own.

The coming abundance of healthcare data promises to transform how we approach healthcare, putting the power of exponential technologies in the patient’s hands and revolutionizing how we live.

Join Me
Abundance-Digital Online Community: I’ve created a Digital/Online community of bold, abundance-minded entrepreneurs called Abundance-Digital. Abundance-Digital is my ‘onramp’ for exponential entrepreneurs – those who want to get involved and play at a higher level. Click here to learn more.

Image Credit: Titima Ongkantong / Shutterstock.com Continue reading

Posted in Human Robots

#434637 AI Is Rapidly Augmenting Healthcare and ...

When it comes to the future of healthcare, perhaps the only technology more powerful than CRISPR is artificial intelligence.

Over the past five years, healthcare AI startups around the globe raised over $4.3 billion across 576 deals, topping all other industries in AI deal activity.

During this same period, the FDA has given 70 AI healthcare tools and devices ‘fast-tracked approval’ because of their ability to save both lives and money.

The pace of AI-augmented healthcare innovation is only accelerating.

In Part 3 of this blog series on longevity and vitality, I cover the different ways in which AI is augmenting our healthcare system, enabling us to live longer and healthier lives.

In this blog, I’ll expand on:

Machine learning and drug design
Artificial intelligence and big data in medicine
Healthcare, AI & China

Let’s dive in.

Machine Learning in Drug Design
What if AI systems, specifically neural networks, could predict the design of novel molecules (i.e. medicines) capable of targeting and curing any disease?

Imagine leveraging cutting-edge artificial intelligence to accomplish with 50 people what the pharmaceutical industry can barely do with an army of 5,000.

And what if these molecules, accurately engineered by AIs, always worked? Such a feat would revolutionize our $1.3 trillion global pharmaceutical industry, which currently holds a dismal record of 1 in 10 target drugs ever reaching human trials.

It’s no wonder that drug development is massively expensive and slow. It takes over 10 years to bring a new drug to market, with costs ranging from $2.5 billion to $12 billion.

This inefficient, slow-to-innovate, and risk-averse industry is a sitting duck for disruption in the years ahead.

One of the hottest startups in digital drug discovery today is Insilico Medicine. Leveraging AI in its end-to-end drug discovery pipeline, Insilico Medicine aims to extend healthy longevity through drug discovery and aging research.

Their comprehensive drug discovery engine uses millions of samples and multiple data types to discover signatures of disease, identify the most promising protein targets, and generate perfect molecules for these targets. These molecules either already exist or can be generated de novo with the desired set of parameters.

In late 2018, Insilico’s CEO Dr. Alex Zhavoronkov announced the groundbreaking result of generating novel molecules for a challenging protein target with an unprecedented hit rate in under 46 days. This included both synthesis of the molecules and experimental validation in a biological test system—an impressive feat made possible by converging exponential technologies.

Underpinning Insilico’s drug discovery pipeline is a novel machine learning technique called Generative Adversarial Networks (GANs), used in combination with deep reinforcement learning.

Generating novel molecular structures for diseases both with and without known targets, Insilico is now pursuing drug discovery in aging, cancer, fibrosis, Parkinson’s disease, Alzheimer’s disease, ALS, diabetes, and many others. Once rolled out, the implications will be profound.

Dr. Zhavoronkov’s ultimate goal is to develop a fully-automated Health-as-a-Service (HaaS) and Longevity-as-a-Service (LaaS) engine.

Once plugged into the services of companies from Alibaba to Alphabet, such an engine would enable personalized solutions for online users, helping them prevent diseases and maintain optimal health.

Insilico, alongside other companies tackling AI-powered drug discovery, truly represents the application of the 6 D’s. What was once a prohibitively expensive and human-intensive process is now rapidly becoming digitized, dematerialized, demonetized and, perhaps most importantly, democratized.

Companies like Insilico can now do with a fraction of the cost and personnel what the pharmaceutical industry can barely accomplish with thousands of employees and a hefty bill to foot.

As I discussed in my blog on ‘The Next Hundred-Billion-Dollar Opportunity,’ Google’s DeepMind has now turned its neural networks to healthcare, entering the digitized drug discovery arena.

In 2017, DeepMind achieved a phenomenal feat by matching the fidelity of medical experts in correctly diagnosing over 50 eye disorders.

And just a year later, DeepMind announced a new deep learning tool called AlphaFold. By predicting the elusive ways in which various proteins fold on the basis of their amino acid sequences, AlphaFold may soon have a tremendous impact in aiding drug discovery and fighting some of today’s most intractable diseases.

Artificial Intelligence and Data Crunching
AI is especially powerful in analyzing massive quantities of data to uncover patterns and insights that can save lives. Take WAVE, for instance. Every year, over 400,000 patients die prematurely in US hospitals as a result of heart attack or respiratory failure.

Yet these patients don’t die without leaving plenty of clues. Given information overload, however, human physicians and nurses alone have no way of processing and analyzing all necessary data in time to save these patients’ lives.

Enter WAVE, an algorithm that can process enough data to offer a six-hour early warning of patient deterioration.

Just last year, the FDA approved WAVE as an AI-based predictive patient surveillance system to predict and thereby prevent sudden death.

Another highly valuable yet difficult-to-parse mountain of medical data comprises the 2.5 million medical papers published each year.

For some time, it has become physically impossible for a human physician to read—let alone remember—all of the relevant published data.

To counter this compounding conundrum, Johnson & Johnson is teaching IBM Watson to read and understand scientific papers that detail clinical trial outcomes.

Enriching Watson’s data sources, Apple is also partnering with IBM to provide access to health data from mobile apps.

One such Watson system contains 40 million documents, ingesting an average of 27,000 new documents per day, and providing insights for thousands of users.

After only one year, Watson’s successful diagnosis rate of lung cancer has reached 90 percent, compared to the 50 percent success rate of human doctors.

But what about the vast amount of unstructured medical patient data that populates today’s ancient medical system? This includes medical notes, prescriptions, audio interview transcripts, and pathology and radiology reports.

In late 2018, Amazon announced a new HIPAA-eligible machine learning service that digests and parses unstructured data into categories, such as patient diagnoses, treatments, dosages, symptoms and signs.

Taha Kass-Hout, Amazon’s senior leader in health care and artificial intelligence, told the Wall Street Journal that internal tests demonstrated that the software even performs as well as or better than other published efforts.

On the heels of this announcement, Amazon confirmed it was teaming up with the Fred Hutchinson Cancer Research Center to evaluate “millions of clinical notes to extract and index medical conditions.”

Having already driven extraordinary algorithmic success rates in other fields, data is the healthcare industry’s goldmine for future innovation.

Healthcare, AI & China
In 2017, the Chinese government published its ambitious national plan to become a global leader in AI research by 2030, with healthcare listed as one of four core research areas during the first wave of the plan.

Just a year earlier, China began centralizing healthcare data, tackling a major roadblock to developing longevity and healthcare technologies (particularly AI systems): scattered, dispersed, and unlabeled patient data.

Backed by the Chinese government, China’s largest tech companies—particularly Tencent—have now made strong entrances into healthcare.

Just recently, Tencent participated in a $154 million megaround for China-based healthcare AI unicorn iCarbonX.

Hoping to develop a complete digital representation of your biological self, iCarbonX has acquired numerous US personalized medicine startups.

Considering Tencent’s own Miying healthcare AI platform—aimed at assisting healthcare institutions in AI-driven cancer diagnostics—Tencent is quickly expanding into the drug discovery space, participating in two multimillion-dollar, US-based AI drug discovery deals just this year.

China’s biggest, second-order move into the healthtech space comes through Tencent’s WeChat. In the course of a mere few years, already 60 percent of the 38,000 medical institutions registered on WeChat allow patients to digitally book appointments through Tencent’s mobile platform. At the same time, 2,000 Chinese hospitals accept WeChat payments.

Tencent has additionally partnered with the U.K.’s Babylon Health, a virtual healthcare assistant startup whose app now allows Chinese WeChat users to message their symptoms and receive immediate medical feedback.

Similarly, Alibaba’s healthtech focus started in 2016 when it released its cloud-based AI medical platform, ET Medical Brain, to augment healthcare processes through everything from diagnostics to intelligent scheduling.

Conclusion
As Nvidia CEO Jensen Huang has stated, “Software ate the world, but AI is going to eat software.” Extrapolating this statement to a more immediate implication, AI will first eat healthcare, resulting in dramatic acceleration of longevity research and an amplification of the human healthspan.

Next week, I’ll continue to explore this concept of AI systems in healthcare.

Particularly, I’ll expand on how we’re acquiring and using the data for these doctor-augmenting AI systems: from ubiquitous biosensors, to the mobile healthcare revolution, and finally, to the transformative power of the health nucleus.

As AI and other exponential technologies increase our healthspan by 30 to 40 years, how will you leverage these same exponential technologies to take on your moonshots and live out your massively transformative purpose?

Join Me
Abundance-Digital Online Community: I’ve created a Digital/Online community of bold, abundance-minded entrepreneurs called Abundance-Digital. Abundance-Digital is my ‘onramp’ for exponential entrepreneurs – those who want to get involved and play at a higher level. Click here to learn more.

Image Credit: Zapp2Photo / Shutterstock.com Continue reading

Posted in Human Robots